The influence of PCP prophylaxis on bacteriuria. Incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients

D. A. Van Dooyeweert, M. M.E. Schneider, J. C.C. Borleffs, A. I.M. Hoepelman*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

Background: Earlier studies have shown that men infected with HIV-1 and a CD4+ cell count below 200 mm3 are at increased risk for bacteriuria. We studied the effect of 3 Pneumocystis carinii (PCP) prophylaxis regimens (low-dose TMP/SMZ, high-dose TMP/SMZ and pentamidine aerosol) on the incidence of bacteriuria and resistance development to TMP/SMZ. Methods: Retrospective analysis of 103 HIV-positive patients. Results: Nine patients using pentamidine had a positive culture (32%), compared to 9 patients using low-dose TMP/SMZ (17%) and 5 patients using high-dose TMP/SMZ (22%). These differences were not significant (P = 0.207). However, almost all episodes in patients using TMP/SMZ were due to infection with a resistant strain. Conclusion: PCP prophylaxis with trimethoprim/sulfamethoxazole does not significantly influence the rate of bacteriuria, probably due to the development of resistance.

Original languageEnglish
Pages (from-to)225-227
Number of pages3
JournalNetherlands Journal of Medicine
Volume49
Issue number6
DOIs
Publication statusPublished - 9 Dec 1996

Keywords

  • PCP prophylaxis
  • TMP/SMX resistance
  • Urinary tract infection

Fingerprint

Dive into the research topics of 'The influence of PCP prophylaxis on bacteriuria. Incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients'. Together they form a unique fingerprint.

Cite this